复星医药(600196.SH):复星医疗与星双健、复星健控拟按持股比例对卓瑞门诊进行增资
格隆汇 8 月 14日丨复星医药(600196.SH)公布,2020年8月14日,公司控股子公司上海复星医疗(集团)有限公司(“复星医疗”)、卓瑞门诊与关联方星双健、复星健控签订《增资协议》,复星医疗与星双健、复星健控拟根据各自所持卓瑞门诊股权比例合计出资人民币2000万元对卓瑞门诊进行增资,其中:复星医疗拟出资人民币1020万元认缴卓瑞门诊新增注册资本人民币1020万元;星双健、复星健控拟分别出资人民币490万元、490万元认缴卓瑞门诊新增注册资本人民币490万元、490万元。
此次交易完成后,卓瑞门诊的注册资本将由人民币4700万元增至人民币6700万元,其中:复星医疗仍将持有卓瑞门诊51%的股权;卓瑞门诊仍为公司控股子公司。
卓瑞门诊系营利性医疗机构,主要通过引进国内外优质医疗资源,提供体检、全科、专科门诊等医疗服务。此次增资款项将主要用于卓瑞门诊的日常运营以及配置医疗设备等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.